Loading...
XNYS
LH
Market cap21bUSD
Dec 05, Last price  
258.39USD
1D
-1.18%
1Q
-7.28%
Jan 2017
101.27%
Name

Laboratory Corporation of America Holdings

Chart & Performance

D1W1MN
XNYS:LH chart
P/E
28.71
P/S
1.65
EPS
9.00
Div Yield, %
1.11%
Shrs. gr., 5y
-3.06%
Rev. gr., 5y
2.40%
Revenues
13.01b
+6.97%
3,327,600,0003,590,800,0004,068,200,0004,505,200,0004,694,700,0005,003,900,0005,542,300,0005,671,400,0005,808,300,0006,011,600,0008,680,100,0009,641,800,00010,441,400,00011,333,400,00011,554,800,00013,978,500,00016,120,900,00014,876,800,00012,161,600,00013,008,900,000
Net income
746m
+78.47%
386,200,000431,600,000476,800,000464,500,000543,300,000558,200,000519,700,000583,100,000573,800,000511,200,000436,900,000732,100,0001,268,200,000883,700,000823,800,0001,556,100,0002,377,300,0001,279,100,000418,000,000746,000,000
CFO
1.59b
+19.44%
574,200,000632,300,000709,700,000780,900,000862,400,000883,600,000855,600,000841,400,000818,700,000739,000,000982,400,0001,175,900,0001,459,400,0001,305,400,0001,444,700,0002,135,300,0003,109,600,0001,955,900,0001,327,700,0001,585,800,000
Dividend
Aug 29, 20240.72 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
IPO date
Apr 24, 1991
Employees
60,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT